Richard Furman, MD

ALL Specialist

location_city Weill Cornell Medical Center

Specialities: Acute Lymphoblastic Leukemia

Spoken languages: English

Clinical Expertise

Acute Lymphoblastic Leukemia

About

Dr. Furman is Director of the CLL Research Center at Weill Cornell Medicine and a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology. His area of focus is on the development of non-chemotherapeutic approaches to treating CLL, and has played an integral part in the development of ibrutinib and idelalisib.